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ABSTRACT In this work, we show that Clostridium difficile phageC2 transduces erm(B), which confers erythromycin resis-
tance, from a donor to a recipient strain at a frequency of 106 per PFU. The transductants were lysogenic forC2 and con-
tained the erm(B) gene in a novel transposon, Tn6215. This element is 13,008 bp in length and contains 17 putative open reading
frames (ORFs). It could also be transferred at a lower frequency by filter mating.
IMPORTANCE Clostridium difficile is a major human pathogen that causes diarrhea that can be persistent and difficult to resolve
using antibiotics. C. difficile is potentially zoonotic and has been detected in animals, food, and environmental samples. C. diffi-
cile genomes contain large portions of horizontally acquired genetic elements. The conjugative elements have been reasonably
well studied, but transduction has not yet been demonstrated. Here, we show for the first time transduction as a mechanism for
the transfer of a novel genetic element in C. difficile. Transduction may also be a useful tool for the genetic manipulation of
C. difficile.
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Clostridium difficile is an important pathogen that causes diar-rhea in humans and animals and has been detected in envi-
ronmental and food samples (1).C. difficile infection is difficult to
resolve and control because antibiotic therapy is a predisposing
factor, and spore formation allows the bacterium to persist in the
environment. The emergence of several virulent strains in the last
10 years has prompted detailed comparative genomic analyses
that have revealed considerable genome plasticity, a large percent-
age of which is mediated by horizontally acquired elements, such
as conjugative transposons (CTn) and phages (2, 3).
Conjugative transposons aremodularmobile genetic elements
that contain regions required for recombination, conjugative
transfer, and regulation. In addition to these core areas, they also
contain accessory regions not directly required for transfer and
transposition, such as antibiotic resistance genes (4). Elements
initially found inC. difficile are able to transfer to other species; for
example, Tn5397 can transfer from C. difficile to Bacillus subtilis
(5) and Enterococcus faecalis (6).
SomeC. difficile phages are capable of lysogeny and integration
of phage genome(s) into the host chromosome. Prophage se-
quences are commonly found inC. difficile isolates,many ofwhich
form infectious particles either spontaneously or following mito-
mycin C induction (7, 8). The five sequenced C. difficile phage
genomes are modular; distinct clusters of homologous genes for
virion structure, cell lysis, lysogeny control, and DNA replication
and recombination were identified. Homologous genes were
found in phages of other clostridia, Streptococcus pneumoniae,
Staphylococcus aureus, Lactobacillus johnsonii, and Bacillus cereus.
The phage genomes are also mosaic, meaning each genome is a
unique composite of gene modules interspersed with nonhomol-
ogous sequences (9–13). Diversity in phage genomes can arise
from recombination events involving host or other phage ge-
nomes, plasmids, or transposons. The ubiquity of prophage se-
quences inC. difficile strains suggests that phage infection is wide-
spread, indicating the potential for transduction. The acquisition
of antimicrobial resistance and virulence genes is mediated by
phage transduction in several clinically important Gram-positive
bacteria, such as S. aureus (14, 15) and E. faecalis (16, 17). Oppor-
tunities for phage-mediated gene transfer occur during bacterial
colonization or infection, as lysogenization has been demon-
strated in vivo for phages of Streptococcus pyogenes and C. difficile
(18–20). In this work, we investigated the ability of phage to trans-
duce antimicrobial resistance markers between C. difficile strains
and showed that phage C2 mediates the transfer of a novel mo-
bile element conferring erythromycin resistance.
RESULTS
C2 mediates transfer of erythromycin resistance from CD80
to CD062.Donor and recipient strains were chosen for transduc-
tion experiments based on C2 susceptibility, determined previ-
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ously (21), and on either the presence or absence of antibiotic
resistance genes, determined in this study (Table 1). Phage C2
(21) was propagated in the erythromycin- and tetracycline-
resistant donor strain CD80 to a concentration of 107 to
108 PFU/ml and used to infect the antibiotic-susceptible strains
CD38, CD062, CD839, and CD6938 to test for transduction of
resistance genes. Erythromycin-resistant CD062 cells were iso-
lated (using either crude or purified phage) at a frequency of 1.2
106 1.0 106 (mean standard deviation) per PFU. Crude
and purified phage suspensions of6 107 PFU/ml and a mul-
tiplicity of infection (MOI) of less than 0.02 did not result in
transduction. There was no growth on control plates when no
recipients were present, showing that the phage preparation did
not contain any bacterial contaminants. Tetracycline resistance
was not transferred to CD062, and erythromycin or tetracycline
resistance transfer did not occur for the other three strains tested.
The donor and all Ermr transductants contained erm(B), as deter-
mined by PCR with primer pair E5/E6 (see Table S1 in the sup-
plemental material). The amplicon sequences from the donor and
transductants were identical. A control mixture of CD80 filtrate
that did not contain C2 and CD062 did not result in
erythromycin-resistant derivatives of CD062, indicating thatC2
is necessary for the transfer of erythromycin resistance fromCD80
to CD062. Two transductants, CD062E1 and CD062E2, were ran-
domly selected for further analysis. Both strains were lysogenized
with C2, as they produced plaques after mitomycin C induction
and contained C2 integrase (results not shown).
The erm(B) gene resides in a novel integrative mobile ele-
ment, Tn6215. The DNA sequences of the transferable erm(B)
gene and the flanking regions were obtained from the donor and
transductants, and the DNA region containing the junction be-
tween the transferred element and the host genomewas located by
Southern hybridization (see Fig. S1 in the supplemental material)
and obtained by comparing the sequence in the transductants and
element-free recipients. The genetic organization of this element
is shown in Fig. 1. The element had the genetic organization of a
mobilizable transposon (Fig. 1) andwas subsequently shown to be
capable of transfer by a conjugation-like mechanism; it was as-
TABLE 1 C. difficile isolates in this study
Isolate Purpose in this study Relevant genotype/phenotypea; ribotype Reference
CD80 Donor tcdA tcdB Ermr Tetr; 010 This study
CD38 Recipient (transduction) tcdA tcdB This study
CD062 Recipient (transduction) tcdA tcdB; 010 (21)
CD839 Recipient (transduction) tcdA tcdB (21)
CD6938 Recipient (transduction) tcdA tcdB (21)
CD062R11 Recipient (conjugation) Rifr (Rifr mutant of CD062) This study
CD062E1 Transductant Ermr; 010 This study
CD062R1112 Transconjugant Ermr Rifr This study
CD062R1146 Transconjugant Ermr Rifr This study
CD062R1170 Transconjugant Ermr Rifr This study
a Ermr, erythromycin resistant; Rifr, rifampin resistant; Tetr, tetracycline resistant.
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FIG 1 Genetic structure of Tn6215 and site of host chromosome integration. In recipient strain CD062, a putative transcriptional regulator gene was
uninterrupted. In donor strain CD80 and transductant strain CD062E1, Tn6215 was integrated into the putative transcriptional regulator gene and the site of
integration, TCC, was duplicated at either end. Predicted functional modules of the 13-kb transposon are color coded as follows: red, resistance; yellow,
mobilization and replication; green, stability; gray, recombination; and white, indeterminate. Restriction sites are indicated as follows: B, BsrGI; H, Hyp99I; and
M, MfeI. Probes used in this study are shown as hatched bars and are shown under their target regions. Homologues in other mobile elements and plasmids are
indicated by colored outlines of putative genes as follows: purple, Tn5397; brown, pMV158; blue, CTnBST; pink, CTnDOT; orange, pSM19035; and turquoise,
Tn5398. Primers P1 to P7 flanking host and transposon junctions are indicated by black arrows.
Goh et al.
2 ® mbio.asm.org November/December 2013 Volume 4 Issue 6 e00840-13
 o
n
 Septem
ber 12, 2018 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
signed transposon number Tn6215 (22). It is 13,008 bp in length,
with 17 open reading frames (ORFs) (Table S2). Tn6215 encodes
a putative serine site-specific recombinase (SSR) (Fig. 1, ORF1)
that is likely to be involved in excision and integration. However,
no circular forms of the transposon in the donor or transductant
were detected byPCRusing outward-facing primers specific to the
left and right ends of the integrated transposon. Using primers
P5/P6 that are specific for the host target site, two amplicons (543
bp and 13.5 kb) were obtained from the donor and transductants,
while only the 543-bp ampliconwas detected in the recipient (data
not shown). Sequencing of the left and right ends of the 13.5-kb
amplicons from the donor and transductants showed Tn6215 in-
tegrated within a transcriptional regulator gene (Fig. 1). The se-
quence of the 543-bp amplicon derived from the donor and trans-
ductants was identical to that of the target site in the recipient,
indicating that either regenerated integration sites or empty sites
were present along with the integrated transposon in the donor
and transductants. Sequence comparisons of the transposon-host
junctions, the host target site, and the regenerated integration site
showed duplication of the target sequence TCC, which is present
at either end of the integrated transposon (Fig. 1 and Fig. 2).
ORF3 is a homologue of the mobilization protein TnpZ from
Tn4451 ofClostridium perfringens (see Table S2 in the supplemen-
tal material) (23). However, ORF3 is truncated, and the upstream
DNA sequence lacks inverted repeats/palindromes forDNAbind-
ing (oriT/RSA regions) and, therefore, probably lacks activity
compared to TnpZ and the archetypal Pre (24, 25). ORF4 shares
the conserved domain RepA_N with replication proteins from
plasmids of low GC Gram-positive bacteria (26). A RepA_N
homologue was found in a Bacteroides conjugative transposon,
CTnBST, which also contained pre and erm(B) (Fig. 3a) (27).
ORF9 is homologous to topoisomerase I, which is required for
excision in the conjugative transposons CTnDOT of Bacteroides
fragilis and CTnPg1 of Porphyromonas gingivalis (28, 29). Al-
though the amino acid sequence relatedness of the Tn6215 topo-
isomerase to homologues from CTnDOT and CTnPg1 (Tn6161)
was only moderate (29% identity over 644 amino acids [aa] for
both) they shared conserved domains for DNA and ATP binding,
strand cleavage and joining sites, C4 zinc finger binding, and
C-terminal repeats.
Genes associated with toxin-antitoxin systems (TAS) were
identified inTn6215. Twoputative type II proteic TAS are present:
a GCN5-related N-acetyltransferase (GNAT) family enzyme-Xre
Host target site 
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AGG
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TCCGGTATCACATACTTA
AGGCCATAGTGTATGAAT
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FIG 2 Sequences of host target site and resulting host and transposon junc-
tions in transductants. The host target site is underlined, and Tn6215 se-
quences are in red.
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FIG 3 Nucleotide sequence comparisons of Tn6215 to the Bacteroides conjugative transposon CTnBST (a) and to the S. pyogenes plasmid pSM19035 (b).
Sand-colored boxes indicate regions of similarity of94%, and blue triangles indicate regions of inversions.
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system and the -- system. A GNAT-Xre TAS was found in
plasmids by comparative genomic analyses only but has not been
experimentally verified (30). The -- system, together with 
and erm(B), was originally described in pSM19035 (31), a multi-
drug resistance-encoding plasmid from Streptococcus pyogenes.
This TAS is important for plasmid maintenance (31–33), has ho-
mologues in Gram-positive and Gram-negative bacteria, and is
associated with antibiotic-resistant strains of Enterococcus faecium
andmethicillin-resistant S. aureus (MRSA) (34, 35). However, the
toxin gene () in Tn6215 is truncated and is predicted to encode
only 52/287 amino acids of the complete  in pSM19035. Nucle-
otide sequence comparison of pSM19035 and Tn6215 showed
high sequence similarity and similar gene organization of topA,
erm(B), ,, , and  (Fig. 3b). While an erm(B)----module
has not been described in transposons, an erm(B)-module was
found in Tn5398 of C. difficile strain 630, and an erm(B)---
(truncated) module was described in a CTn1-like element in
C. difficile strains M68 and 2007855 (36). The M68 genome has
nucleotide sequence similarity to Tn6215 genes 1 to 5, 7, 10 to 12,
13 to 16, and 17 in distinct regions as determined by BLASTn
(nucleotides 1760244 to 1756132, 1753494 to 1752687, 3801235
to 3803491, 3800108 to 3801236, and 1750963 to 1750400, respec-
tively). The previously annotated orf298 of Tn5398 (37) is pre-
dicted as  in this study.
Tn6215 was transferred by filter mating. To determine
whether Tn6215 is conjugative, we carried out filtermating exper-
iments using the C2-free strain CD80 as the donor and the
rifampin-resistant derivative of CD062, CD062R11, as the recipi-
ent. Transconjugants were selected on brain heart infusion (BHI)
medium containing rifampin (25 mg/liter) and erythromycin
(10 mg/liter). Erythromycin-resistant transconjugants appeared
at a frequency of 1.8  109 per CFU of the donor. Southern
hybridization with the RF amplicon probe (Fig. 1) containing a
Tn6215-host junction confirmed the integration of Tn6215 into
the transconjugants (see Fig. S1 in the supplemental material) and
showed that Tn6215 entered the genome at the same site in the
transconjugants as it occupied in the donor (Fig. 1; Fig. S1).
Southern hybridizationwith a probe specific only for the right end
of Tn6215 (Fig. 1) showed that there were at least two copies of the
element in the donor, CD80, but only one in the CD062 transduc-
tants and transconjugants (Fig. S2). Unlike when Tn6215 is trans-
ferred by transduction, the transconjugants did not contain a copy
of C2.
DISCUSSION
This is the first report of gene transfer by phage transduction be-
tween C. difficile strains. Erythromycin resistance contained
within Tn6125was transferred byC2 fromCD80 toCD062. This
element could also be transferred by a conjugation-like mecha-
nismbyfiltermating, resulting in ErmrTets transconjugants but at
a much lower frequency. Transductants were lysogens of C2,
whereas transconjugants did not contain the phage. Once trans-
ferred, Tn6215 existed as a single copy in both transductants and
transconjugants at the same integration site. Although we did not
detect circularized Tn6215, empty or regenerated sites in donors
and transductants were detected along with integrated Tn6215.
The most likely explanation for this is that the transposon excises
at a low frequency, resulting in a small number of individual cells
that contain a regenerated target site. Presumably the circular
form is present in too low a concentration to detect by PCR, as it
will be lost from the cell, whereas the regenerated target will re-
main.
There are two putative type II proteic TAS in Tn6215, a GCN5-
related N-acetyltransferase (GNAT) family enzyme-Xre system
and the-- system.However, in the latter system, the Zeta toxin
is truncated and contains only 52 amino acids of the N-terminal
region, and previous work has shown that more than 79 amino
acids are required for function (31). Therefore, the toxin is un-
likely to be functional, but the antitoxin Epsilon is intact. A system
where just the antitoxin is present has been observed in phage T4,
where the Dmd protein (antitoxin) is required for successful in-
fection of hosts containing chromosomal toxin/antitoxin systems
(38). A dmdT4phagemutantwas unable to propagate in host cells
because phage infection led to the degradation of unstable anti-
toxins (RlnB or LsoB) and activation of toxins (RlnAor LsoA) that
resulted in inhibition of growth in host cells (38). Possibly the
Tn6215 epsilon antitoxin has a similar role in stabilizing host cells
under conditions that trigger toxin activity.
GNAT can have a range of enzymatic functions, including re-
sistance to antibiotics, regulation of sporulation (39), and cell wall
recovery (40), but there is no evidence in the literature of toxicity
mediated byGNAT.While some transcriptional regulators and/or
antitoxins have a helix-turn-helix (HTH)_XRE domain (41, 42),
the putative XRE located next to GNAT suggests that it functions
as a transcriptional regulator of the GNAT gene rather than as an
antitoxin. Further experiments are needed to determine the func-
tions of the genes encoding the putative TAS GNAT-Xre and
Epsilon-Zeta in Tn6215.
Although all four strains tested as recipients were susceptible to
C2 infection, only one of the four acquired erm(B) by transduc-
tion, indicating that the transduction conditions may not be op-
timal. Susceptibility to infection by a transducing phage does not
necessarily result in transduction, as shown in other studies (17,
43). A possible explanation for the inability to transfer Tn6215 to
the other strains is that they lack a transposon integration site.
However, PCR and sequencing analysis indicated that the integra-
tion site was intact. Further experiments using more donors and
recipients in various growth phases and screening for the transfer
of more genetic markers are needed to determine how prevalent
phage transduction is as amechanism of horizontal and antibiotic
resistance gene transfer in C. difficile.
MATERIALS AND METHODS
Bacterial strains and phage. All C. difficile isolates were stored either as
stocks in brain heart infusion (BHI) broth (Oxoid) with 20% (vol/vol)
glycerol (Sigma) at 70°C or as working spore stocks in cooked-meat
medium (Oxoid) and were grown in BHI broth or BHI agar supple-
mented with 5% horse blood in an anaerobic cabinet as previously de-
scribed (21). The relevant properties of five clinical C. difficile isolates
(from Sir Charles Gairdner Hospital, Perth, Western Australia) with
known susceptibility to C2 infection (21) are shown in Table 1. PCR
detection of erm(B), tet(M), Tn916, Tn5397, tcdA, and tcdB was carried
out under the general PCR conditions described below using genomic
DNA (gDNA) and the primers listed in Table S1 in the supplemental
material.
The temperate phage C2 was propagated in a donor strain, CD80,
using log-phase cultures and anaerobe basal agar as previously described
(21). Phage suspensions were concentrated by using polyethylene glycol
(PEG) and chloroform (crude phage suspension). Purified phagewas pre-
pared in a preformed CsCl density gradient (44).
Microdilution for antimicrobial MIC determination. The determi-
nation of the antimicrobial susceptibilities of C. difficile strains was based
Goh et al.
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on theClinical and Laboratory Standards Institute (CLSI) guidelines (45).
Twofold dilutions of antimicrobials (chloramphenicol, erythromycin,
and tetracycline; Sigma) were made in BHI broth and in 100-l aliquots
per well of a 96-well plate. The final antimicrobial concentrations ranged
from 0 to 256 mg/liter. C. difficile cultures (16 to 18 h) were diluted to a
final concentration of105 CFU/ml. The cultures were incubated anaer-
obically (80% N2, 10% H2, and 10% CO2) at 37°C for 48 h, and the MIC
of each antimicrobial for each bacterial strain was determined. The anti-
microbials tested were chosen based on reports of resistance genes in
C. difficile (5, 46, 47).
Genomic DNA preparation and PCR reactions. C. difficile strains
were grown for 18 to 20 h in 5 ml BHI broth supplemented with appro-
priate antibiotics for gDNA extraction using the Gentra Puregene yeast/
bacteria kit (Qiagen). Three DNA polymerases, Crimson Taq, Phusion
high-fidelity PCR master mix, and Phire II DNA polymerase (all New
EnglandBiolabs), were used for PCR reactions in this study as indicated in
Table S1 in the supplemental material. The annealing temperatures and
extension times of primers are shown in Table S1. The typical reaction
conditions for PCRs using crimson Taq were 1 crimson Taq reaction
buffer, 0.2Mdeoxynucleoside triphosphates (dNTPs), 0.125 U crimson
Taq DNA polymerase, and 20 ng DNA in a 25-l volume. The typical
cycling conditions were 95°C for 30 s, 35 cycles of 95°C for 30 s, primer-
specific temperature for 40 s, 68°C for a primer-specific number of sec-
onds, and a final extension of 68°C for 5min. Themultiplex PCRmixture
contained 0.5 M each primer for the gene of interest, 50 nM each prim-
ers PS13/PS14, 1CrimsonTaq reaction buffer, 0.26MdNTPs, 0.625U
crimson Taq DNA polymerase, and 20 ng DNA in 25 l. The cycling
conditions were 95°C for 30 s, 35 cycles of 95°C for 30 s, primer-specific
temperature for 40 s, 68°C for 1 min, and a final extension of 68°C for
5 min. The typical reaction conditions for PCR using Phusion were 1
Phusion master mix, 0.5 M of each primer, and 1 to 20 ng DNA in a
20-l volume. The typical cycling conditions were 98°C for 30 s, 35 cycles
of 98°C for 5 s, primer-specific temperature for 10 s, 72°C for a primer-
specific number of seconds, and a final extension of 72°C for 5 min. The
typical reaction conditions for PCR of DNA ligation reactions using Phire
II DNApolymerase were 1 reaction buffer, 200MdNTPs, 2l ligation
reaction buffer, 0.5 M each primer, and 0.4 l polymerase. The cycling
conditions were 98°C for 30 s, 35 cycles of 98°C for 5 s, primer-specific
temperature for 5 s, 72°C for a primer-specific number of seconds, and a
final extension of 72°C for 1 min.
Phage transduction andanalysis of transductants.Transductionwas
carried out anaerobically (80%N2, 10%H2, and 10%CO2), except for the
centrifugation steps. Log-phase cultures of the recipients weremixedwith
either the crude phage suspension or purified phage (see above) to achieve
anMOI of 0.02 to 0.3 in a volume of 1ml. Phage-free filtrates of the donor
were used for some experiments; uninfected bacterial lawns of CD80were
resuspended in phage buffer, filtered, and processed with PEG and chlo-
roform as for phage-infected lawns (44). Bacterial and phage concentra-
tions were standardized to 1 107 to 5 107 CFU/ml and 1 107 to 5
107 PFU/ml, respectively. A recipient-only control containing only bacte-
ria and phage buffer was included in each experiment. Phage mixed with
the recipient was incubated for 1 h at 37°C and then centrifuged at 14,000
 g for 30 s. The supernatants were removed, and the cells were washed in
1ml BHI broth. Thewashingwas repeated, and the cells were resuspended
in 150l of BHI broth. The cells were spread plated in 50-l volumes onto
BHI agar plates supplemented with either tetracycline (10 mg/liter) or
erythromycin (50 mg/liter) and incubated for 48 to 72 h. Putative trans-
ductants were checked for the presence of erm(B) by using PCR primers
E5/E6 (see Table S1 in the supplemental material), and two transductants
were chosen for further analysis. The transduction frequency was calcu-
lated as the number of transductants per PFU. Crude phage suspensions
were retrospectively inoculated onto BHIS(TA) (brain heart infusion
[Oxoid] supplemented with yeast extract [5 mg/ml; Oxoid], L-cysteine
[0.1% wt/vol; Sigma], and sodium taurocholate [0.1% wt/vol; Sigma])
agar and broth to check that they were free of bacterial cells/spores.
Screening for C2 in transductants by mitomycin C induction and
plaque assay on strainCD062was performed as described previously (21).
In addition, PCR detection of the C2 integrase gene and integration site
in transductants was carried out (see Table S1 in the supplemental mate-
rial). To control for the integrity of the template, 16S rRNAprimers PS13/
PS14 were included in the same reaction mixture or used in separate
reaction mixtures (48) as described below.
Sequencingof erm(B)mobile elementanddeterminationof integra-
tion site in transductants. The mobile element containing erm(B) was
amplified from CD80 and CD062E1 in four parts and sequenced by the
Sangermethod (EurofinsMWGOperon, Germany). Primers SG2F/SG3R
and TRR4/TPLHSout1 were used with gDNA, while primers invF2/
invR2, invF2.1/invR2.1, and invF3/invR3 were used in ligation-assisted
PCR (see Table S1 in the supplemental material). CD80 gDNA (0.5 to
1g) was completely digested with either Hpy99I or BsrGI (New England
Biolabs) and then self-ligated with T4 DNA ligase (10 U per reaction
mixture volume; Fermentas) at 16°C for 18 h, and 16 to 32 ng was used in
PCR. Sequences were analyzed and assembled into contigs with CLC
Workbench version 6, ORFs were predicted with GeneMark, sequence
alignments and homology searches were carried out using BLASTN,
BLASTP, and ClustalW, and repeats/palindromes were searched for using
einverted (http://emboss.bioinformatics.nl/cgi-bin/emboss/einverted),
Inverted Repeats Finder (http://tandem.bu.edu/cgi-bin/irdb/irdb.exe),
and REPFIND (http://zlab.bu.edu/repfind/form.html).
The integration site of the erm(B)mobile element in transductantswas
confirmed by Southern hybridization as described below. Primers P5/P6
(Fig. 1; see Table S1 in the supplemental material) were used to detect the
integrated erm(B) mobile element and regenerated or empty integration
sites in the donor, recipient, and transductants. Circular molecules of the
erm(B) mobile element in transductants were searched for using four
primer pairs (P2/P4, P1/P4, P2/P3, and P1/P3) reading out of the ends of
the element (Fig. 1; Table S1).
Ribotyping. Ribotyping of CD80, CD062, and CD062E1 was carried
out as previously described (49) except that electrophoresis was done
using capillary gel electrophoresis (Qiagen) (50).
Filter mating and analysis of transconjugants compared to trans-
ductants. Filter mating assays were carried out as previously described
(51) using a spontaneous rifampin-resistant mutant of CD062 as the re-
cipient. This mutant was selected on BHI agar with 5% horse blood and
25 mg/liter rifampin to generate CD062R11 (Table 1); transconjugants
were selected on rifampin (25 mg/liter) and erythromycin (10 mg/liter)
after a 5-day incubation. All putative transconjugants were tested bymul-
tiplex PCR for 16S rRNA and a gene encoding an ABC-transport system
(see Table S1 in the supplemental material) that is present only in the
donor, as described below. The integration site of the erm(B) element in
transconjugants was determined by PCR with primers specific for the
integration site in transductants, P5/P2 for the left end and P4/P7 for the
right end (Fig. 1; Table S1).
Genome sequencing to differentiate donor and recipient.As the do-
nor and recipient strains were highly similar, we needed to find genetic
markers for a PCR assay to determine real transconjugants after filter
matings. Genes unique to the donor and recipients were found by whole-
genome sequencing using the Illumina genome analyzer IIx at low
(~100) coverage. Initially, the sequence reads from the recipients were
filtered by excluding those found to align to the donor. This was done
using the BWA alignment package (52). The remaining reads were assem-
bled using the A5 pipeline (53), and contigs were annotated against the
genome of CD630 using the xBASE annotation pipeline (54–59). A simi-
lar process was followed to obtain donor-specific contigs. Candidate
marker genes were selected to exclude hypothetical genes without a
known function and genes on known transposons or phages. Finally,
primers CD80C3U57F/CD80C3U57R (Table S1)were designed for a can-
didate marker gene with 99% (1,035/1,038) sequence similarity to a gene
in CD630 encoding an ABC-type transport system (CD630_08760), pres-
ent only in the donor, and experimentally verified by PCR as described
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above. The PCR assay was used to distinguish transconjugants from spon-
taneous rifampin-resistant mutants of the donor after filter matings.
Southern hybridization. For detection of the erm(B) mobile element
integration site in transductants and transconjugants, the RF amplicon
was used as a probe (Fig. 1). The PCR conditions for obtaining the RF
ampliconusing invF3/invR3 are described inTable S1 in the supplemental
material. For determining the copynumber of the erm(B)mobile element,
a PCR amplicon of P4/C2Tn3=end (Table S1), containing the 3= end of the
mobile element, was used as a probe (Fig. 1). MfeI (Fermentas)-digested
gDNA (3g) of CD062, CD062R11, CD80, andCD062 transductants and
CD062 transconjugants served as the templates for hybridization of
digoxigenin (DIG)-labeled probes, at 40°C for the RF amplicon probe and
49°C for the 3=-end probe. Detection was carried out as recommended for
the DIG DNA labeling and detection kit (Roche).
GenBank accession number. The complete sequence of Tn6215 is
deposited in GenBank with the accession number KC166248.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org
/lookup/suppl/doi:10.1128/mBio.00840-13/-/DCSupplemental.
Figure S1, PDF file, 0.3 MB.
Figure S2, PDF file, 0.5 MB.
Table S1, DOCX file, 0.1 MB.
Table S2, DOCX file, 0.1 MB.
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